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Abstract
We report one case of a 78-year-old woman who referred to our hospital because of a progressive
right hemiparesis. On clinical examination a painless large soft mass in the left parietal region was
observed. CT and MRI revealed an extra-axial mass in the in the left fronto-temporo-parietal
region. The lesion was totally excised despite the bleeding tendency. Histology disclosed the
presence of a plasmacytoma. Postoperative, the patient developed an epidural hematoma that
required immediate evacuation. On further investigation active tuberculosis was detected. On
follow up examination 1 year later no tumor recurrence or evidence of multiple myeloma was
detected.
Introduction
Plasmacytes are responsible for the production of anti-
bodies, consisting an important factor of the immune sys-
tem. Plasmacytomas are referred to benign lesions that
may progress to multiple myeloma, a fatal neoplasm [1].
Skull plasmacytomas are unusual tumors accounting for
4% of all plasma cell tumors [1-6]. We report on a rare
case of a skull plasmacytoma in a patient with active
tuberculosis and no evidence of multiple myeloma that
was successfully treated by surgery alone.
Case Report
Presentation
A 78-year-old Caucasian woman from Greece was referred
to our hospital because of a progressive weakness of the
right upper and lower extremities and inability to walk.
The clinical examination revealed a right hemiparesis,
positive ipsilateral Babinski and Barré signs and a painless
large soft mass in the left parietal region, which could be
easily missed because of her long hair. The patient suf-
fered from headache during the last 6 months, without
alterations in mental status, as it was reported from her
daughter.
Diagnostic Tests
A brain CT was performed and revealed an extradural
mass that was homogenous enhance after intravenous
contrast administration. There was bone erosion and the
lesion had regions of calcifications. MRI that ensued
showed a large (9.8 × 9 × 3 cm) extra-axial mass with iso-
intense signal on T1-weighted images, hyperintense signal
on T2- weighted images with intense and homogeneous
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trated the adjacent bone without dura involvement, giv-
ing rise to the subcutaneous mass in the left fronto-
temporo-parietal region. Perifocal edema in the left hem-
isphere and a midline shift of approximately 8 mm were
also detected. For further investigation, brain SPECT with
99mTc-Tetrofosmin was performed. There was increased
radiotracer accumulation consisted with a lesion of high
metabolic activity and vascularity [Figure 1C].
Interventions
The patient was operated upon via a left fronto-temporo-
parietal craniectomy. Intraoperative a soft purplish, easily
separated from dural surface lesion was discovered that
was not encapsulated and was originated from the diploe.
The overlying skin was normal and the galea was not
involved. There was a bleeding tendency, nevertheless the
lesion was totally excised and a cranioplasty with bone
cement was performed. Histology revealed a highly cellu-
lar tumor, composed of monoclonal plasma cells positive
for immunoglobin lambda light chain. The diagnosis was
plasmacytoma of the skull. Six hours later the patient
developed an epidural hematoma that required an imme-
diate evacuation [Figure 2]. The patient was admitted to
the intensive care unit for four days. After readmission to
neurosurgery department her neurological status was
gradually improved with an accepted cosmetic appear-
ance of the cranial vault. For further investigation to detect
possible multiple myeloma a bone scan was performed
that revealed no osteolytic lesions. On laboratory exami-
nation there was no evidence of systemic myelomatous
changes, cancer or anemia. M component was not
detected in serum protein electrophoresis, Bence-Jones
protein and excretion of immunoglobin elements was not
found in urine. The patient underwent bone marrow aspi-
ration and bronchoscopy which were also negative. Saline
cultures revealed active tuberculosis.
Outcome
Postoperative the patient received treatment for tubercu-
losis (ethambutol, pyrazinamide and rifampicin for nine
months) and adjuvant treatment for the plasmacytoma
(thalidomide, melphalan and dexamethasone). One year
after the initial diagnosis the patient was free of recurrence
without having received additional radiotherapy.
Discussion
Multiple myeloma has an incidence of 4 cases per
100.000/year and constitutes approximately 1% of all
malignant neoplasms and 15% of all blood neoplasm's
[3]. It is characterized by a decrease in the amount of beta-
lymphocytes and the mean age of the patients is 60 years
[1]. Plasmacytoma is a myelomatous mass that may be
solitary, in combination with multiple myeloma or may
progress to a generalized disease [7-9]. The diagnosis of
solitary plasmacytoma can be made only when there is no
evidence of multiple myeloma based on bone marrow
aspiration, electrophoresis of serum and urine protein
and no other lesion on complete skeletal survey [4,7].
Multiple myeloma predisposes to infections with atypical
microbes including mycobacteria [10]. Our patient suf-
fered from tuberculosis but there was no evidence of mul-
tiple myeloma.
Plasmacytoma of the skull is a rare finding [6]. It may
involve the cranial vault, skull base and the orbit. Present-
ing symptoms and signs are not specific because plasma-
cytoma lacks neurological symptoms, except of cases of
intraparenchymal dissemination or compression of brain
and cranial nerves [9]. In that case symptomatology
depends on the lesion's location [3]. Cosmetic skull
deformities have been reported to be a usual cause for
referring to a specialist [5]. In our case, except from the
severe clinical deterioration, a problem of cosmetic
appearance was also evident.
On radiological investigation CT and MRI may provide
clues to narrow the differential [9]. We also performed a
brain SPECT with 99mTc-TF in order to functionally char-
acterize the lesion. 99mTc-TF is a lipophilic cationic
diphosphine routinely used for myocardial perfusion
imaging. Its whole uptake mechanism depends mainly on
regional blood flow and cell membrane integrity [11]. In
our case we observed an avid uptake of 99mTc-TF that is
explained by the high vascularity and metabolic activity of
the tumor, but also by the lesion's absence of blood-brain
barrier which allows leakage of the 99mTc-TF from the
cells. Nevertheless, further investigation is necessary to
determine the usefulness of 99mTc-TF brain SPECT in the
diagnosis of this tumor type.
Total surgical resection followed by adjunctive radiation
therapy has been advocated as an effective treatment in
the majority of skull plasmacytomas [6]. Nevertheless,
Arienta et al reported that if total resection has been
achieved then radiotherapy should be reserved for case of
A. Axial T1-weighted MR image revealing an isointense signal mass n the left temporoparietal regionFigure 1
A. Axial T1-weighted MR image revealing an isoin-
tense signal mass in the left temporoparietal region. 
B. Marked enhancment after contrast administration. C. 
Reconstructed axial SPECT slice revealing significant 99mTc-
Tetrofosmin uptake in the left temporoparietal region.Page 2 of 3
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complete cure after biopsy and radiotherapy, because
plasma cell neoplasms are exquisitely radiosensitive [12].
In our case because of the complete tumoral excision, reg-
ular follow-up was preferred reserving radiotherapy for
the future. Intraoperative, plasmacytoma may be a highly
vascular tumor, therefore the neurosurgeon should be
careful to perform a thorough hemostasis. A case of car-
diac arrest from excessive blood loss has been reported
[6]. In our case the tumor's bleeding tendency resulted in
patient's reoperation due to an epidural hematoma. Addi-
tionally, based on our experience, we recommend craniec-
tomy and cranioplasty, because there is a report of high
recurrence rate from the remained cells of the tumor to the
inner surface of the bone flap [3]. The reconstruction of
the cranial vault improved also the cosmetic deformity.
To conclude, plasmacytoma of the cranial vault is a rare
clinical entity that demands neurosurgeon's and hematol-
ogist's cooperation. Laboratory and imaging evaluation
are of paramount importance to exclude systematic
involvement. Careful surgical resection if total may be
adequate for the disease control. Nevertheless, close fol-
low-up with regular life-long examinations are important
in order to avoid a generalized incurable disease.
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A. Epidural hematoma six hours after plasmacytoma's excisionFigure 2
A. Epidural hematoma six hours after plasmacytoma's excision. B. Hematoma evacuation.Page 3 of 3
(page number not for citation purposes)
